Singapore Biomedical Sciences Group Director Yeoh Keat Chuan: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Singapore government official talks about the country’s R&D strengths and how it is handling increased competition from other Asian nations.
You may also be interested in...
Artisan, Singapore's A-Bio Join Forces On Recombinant Sepsis Candidate
Artisan Pharma and Singapore-based A-Bio Pharma have established a relationship under which the Asian firm will provide process development, scale-up and manufacturing support for Artisan's investigational recombinant protein ART-123, the firms announced Sept. 17
Artisan, Singapore’s A-Bio Join Forces On Recombinant Sepsis Candidate
Massachusetts firm is first-of-a-kind venture capital-funded, Japanese spinoff to focus on a top-priority compound, Artisan CEO tells “The Pink Sheet” DAILY.
Artisan, Singapore’s A-Bio Join Forces On Recombinant Sepsis Candidate
Massachusetts firm is first-of-a-kind venture capital-funded, Japanese spinoff to focus on a top-priority compound, Artisan CEO tells “The Pink Sheet” DAILY.